0 NASDAQ Companies - August 14, 2020Qorvo Announces Extension of Exchange Offer for 4.375% Senior Notes Due 2029GREENSBORO, N.C., Aug. 14, 2020 (GLOBE NEWSWIRE) — Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect […]Read More
0 NASDAQ Companies - August 14, 2020Whole Earth Brands, Inc. Reports Second Quarter 2020 Financial ResultsBranded CPG product revenues increased 4.3% (6.6% constant currency) in the second quarterBusiness combination between Act II and Merisant Company […]Read More
0 NASDAQ Companies - August 14, 2020Celsion Corporation Reports Second Quarter 2020 Financial Results and Provides Business UpdateInitiates Promising Phase II Study of GEN-1 in Advanced Ovarian CancerWill Continue Following Patients in Phase III OPTIMA Study for […]Read More
0 NASDAQ Companies - August 14, 2020BIO-key Reports Q2 Results and a Post-Recapitalization Cash Position of Approximately $18M – Investor Webcast Today at 10am ETWALL, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric and other […]Read More
0 NASDAQ Companies - August 14, 2020Cancer Genetics Reports Second Quarter 2020 Financial ResultsRUTHERFORD, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery […]Read More
0 NASDAQ Companies - August 14, 2020Avenue Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate HighlightsNEW YORK, Aug. 14, 2020 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development […]Read More
0 NASDAQ Companies - August 14, 2020Ocugen Provides Business Update and Second Quarter 2020 Financial ResultsTwo Additional Orphan Drug Designations Granted for OCU400 Modifier Gene Therapy ProgramConference Call and Webcast Today at 8:30 a.m. ETMALVERN, […]Read More
0 NASDAQ Companies - August 14, 2020ContraFect Reports Second Quarter 2020 Financial Results and Provides Business UpdateExebacase Phase 2 study results published in the Journal of Clinical InvestigationContinued patient enrollment in ongoing Phase 3 DISRUPT study […]Read More
0 NASDAQ Companies - August 14, 2020Nephros Names Andy Astor President and Chief Executive Officer Daron Evans to Remain Senior Science Advisor and CEO of Specialty Renal ProductsSOUTH ORANGE, NJ, Aug. 14, 2020 (GLOBE NEWSWIRE) […]Read More
0 NASDAQ Companies - August 14, 2020Bio-Path Holdings Reports Second Quarter 2020 Financial ResultsHOUSTON, Aug. 14, 2020 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery […]Read More